Key facts
- This page summarizes Robert L. Nussbaum's Form 4 filing for Invitae Corp.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Dec 2023, 21:20.
Robert L. Nussbaum - 20 Dec 2023 Form 4 Insider Report for Invitae Corp
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- N/A
- Reported as of
- 20 Dec 2023
- Net transaction value
- -$11,278
- SEC form
- 4
- Accepted by SEC
- 21 Dec 2023, 21:20:16 UTC
- Prior SEC filing
- 15 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas R. Brida, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert L. Nussbaum filed Form 4 for Invitae Corp on 21 Dec 2023.
Change
- Previous filing in this sequence was filed on 15 Jun 2023.
- Current net transaction value: -$11,278.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NVTA
transaction
Common Stock
Tax liability
- Transaction value
- $11,278
- Shares
- -17,404
- Change %
- -3.1%
- Price
- $0.6480
- Shares after
- 551,941
- Date
- 20 Dec 2023
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents the withholding of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
Footnote F2
Includes an aggregate of 282,241 shares of common stock issuable pursuant to restricted stock units that have not vested.